RNA toxicity in human disease and animal models: From the uncovering of a new mechanism to the development of promising therapies

被引:52
|
作者
Sicot, Geraldine
Gomes-Pereira, Mario [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2013年 / 1832卷 / 09期
关键词
Animal model; RNA toxicity; Trinucleotide repeat; Microsatellite expansion; Myotonic dystrophy; RNA splicing; MYOTONIC-DYSTROPHY TYPE-1; PRE-MESSENGER-RNA; EXPANDED CTG REPEATS; FRAGILE-X PREMUTATION; 3 UNTRANSLATED REGION; TRINUCLEOTIDE REPEAT; SPINOCEREBELLAR ATAXIA; SKELETAL-MUSCLE; CUG REPEATS; TRIPLET-REPEAT;
D O I
10.1016/j.bbadis.2013.03.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutant ribonucleic acid (RNA) molecules can be toxic to the cell, causing human disease through trans-acting dominant mechanisms. RNA toxicity was first described in myotonic dystrophy type 1, a multisystemic disorder caused by the abnormal expansion of a non-coding trinucleotide repeat sequence. The development of multiple and complementary animal models of disease has greatly contributed to clarifying the complex disease pathways mediated by toxic RNA molecules. RNA toxicity is not limited to myotonic dystrophy and spreads to an increasing number of human conditions, which share some unifying pathogenic events mediated by toxic RNA accumulation and disruption of RNA-binding proteins. The remarkable progress in the dissection of disease pathobiology resulted in the rational design of molecular therapies, which have been successfully tested in animal models. Toxic RNA diseases, and in particular myotonic dystrophy, clearly illustrate the critical contribution of animal models of disease in translational research: from gene mutation to disease mechanisms, and ultimately to therapy development. This article is part of a Special Issue entitled: Animal Models of Disease. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1390 / 1409
页数:20
相关论文
共 50 条
  • [21] Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models
    Uno, Narumi
    Abe, Satoshi
    Oshimura, Mitsuo
    Kazuki, Yasuhiro
    JOURNAL OF HUMAN GENETICS, 2018, 63 (02) : 145 - 156
  • [22] Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models
    Narumi Uno
    Satoshi Abe
    Mitsuo Oshimura
    Yasuhiro Kazuki
    Journal of Human Genetics, 2018, 63 : 145 - 156
  • [23] Chronic Neuroinflammation in Alzheimer's Disease: New Perspectives on Animal Models and Promising Candidate Drugs
    Millington, Christopher
    Sonego, Sandra
    Karunaweera, Niloo
    Rangel, Alejandra
    Aldrich-Wright, Janice R.
    Campbell, Iain L.
    Gyengesi, Erika
    Muench, Gerald
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [24] The ERG in drug development: translation from animal models to human
    Mitchell Brigell
    Documenta Ophthalmologica, 2009, 118 : 1 - 1
  • [25] Translating Therapies for Huntington's Disease from Genetic Animal Models to Clinical Trials
    Hersch S.M.
    Ferrante R.J.
    NeuroRX, 2004, 1 (3): : 298 - 306
  • [26] The ERG in drug development: translation from animal models to human
    Brigell, Mitchell
    DOCUMENTA OPHTHALMOLOGICA, 2009, 118 (01) : 1 - 1
  • [27] Thrombotic Microangiopathies: From Animal Models to Human Disease and Cure
    Caprioli, Jessica
    Remuzzi, Giuseppe
    Noris, Marina
    EXPERIMENTAL MODELS FOR RENAL DISEASES: PATHOGENESIS AND DIAGNOSIS, 2011, 169 : 337 - 350
  • [28] Determinant spreading: lessons from animal models and human disease
    McCluskey, J
    Farris, AD
    Keech, CL
    Purcell, AW
    Rischmueller, M
    Kinoshita, G
    Reynolds, P
    Gordon, TP
    IMMUNOLOGICAL REVIEWS, 1998, 164 : 209 - 229
  • [29] New directions for HIV vaccine development from animal models
    McChesney, Michael B.
    Miller, Christopher J.
    CURRENT OPINION IN HIV AND AIDS, 2013, 8 (05) : 376 - 381
  • [30] Advances in therapy for polycystic kidney disease: From animal models to human disease
    Torres, VE
    FASEB JOURNAL, 2004, 18 (05): : A778 - A778